Brextanib (Brexivance)
Product detail for Brextanib, INN: brextanib. Therapeutic area: Oncology. This record shows all linked substances, markets, applications, presentations, and labeling artefacts.
Product ID
PROD-019
INN
brextanib
Therapeutic Area
Oncology
Status
Active
Owner
Dmitri Volkov
Created
2022-05-26
Last Updated
2023-09-06
Markets
6
Presentations
| Form | Strength | Route |
|---|---|---|
| Concentrate for solution for infusion | 1 mg/mL | Oral |
Active Substances
| ID | Name | INN | CAS | Type | Status |
|---|---|---|---|---|---|
| SUB-042 | EDTA disodium | edta disodium | 51473-63-3 | small-molecule | Active |
| SUB-049 | Microcrystalline cellulose | microcrystalline cellulose | 73320-86-3 | small-molecule | Active |
Applications (3)
| Application # | Market | Procedure Type | Status | Owner | Submitted |
|---|---|---|---|---|---|
| Roszdravnadzor-2021-0019 | Mexico | sBLA | Approved | Marcus Webb | 2023-08-31 |
| SwissMedic-2021-0049 | Mexico | Type II Variation | In Progress | Marcus Webb | 2023-10-07 |
| Roszdravnadzor-2021-0079 | Mexico | Lifecycle Extension | Failed | Marcus Webb | 2022-06-23 |
Markets (6)